personal genomicsScience23andMe moving into clinical diagnostics?By Daniel MacArthurScienceNavigenics' lame attempt at cut-price geneticsBy Daniel MacArthurSciencePersonal genomics customers: Case Western Uni wants youBy Daniel MacArthurScienceGene Genie #42 - focus on personalised geneticsBy Daniel MacArthurSciencePeering into the Genetic Future: trends in human genomics in 2009By Daniel MacArthurScienceThe diversification of consumer genomicsBy Daniel MacArthurScienceThe importance of confusionBy Daniel MacArthurScienceSteven Pinker in the NY TimesBy Daniel MacArthurSciencePersonal genomics in 2008: the year in reviewBy Daniel MacArthurScienceThe impact of gene patents on the future of personal genomicsBy Daniel MacArthurScience23andMe offers family discount, just in time for ChristmasBy Daniel MacArthurScienceAdvice for doctors on dealing with personal genomics customersBy Daniel MacArthurScienceFDA interested in collaborating with personal genomics companiesBy Daniel MacArthurScienceAustralia to get its own personal genomics company?By Daniel MacArthurScienceNot that I'm bitter or anything...By Daniel MacArthurScienceNature special issue on personal genomicsBy Daniel MacArthurScienceAfrican and Asian genome sequences: the last of the single human genome papers?By Daniel MacArthurScienceGenome scans for the whole family: 23andMe research director talks about genotyping her kidsBy Daniel MacArthurScienceGenomic magicBy Daniel MacArthurScienceNavigenics to add gene sequencing to its personal genomic serviceBy Daniel MacArthurScienceGoogle co-founder at increased risk of Parkinson's, according to 23andMeBy Daniel MacArthurScienceCheap personal genomics: the death-knell for the industry?By Daniel MacArthurScienceCheap as chips: 23andMe slashes the price of personal genomicsBy Daniel MacArthurScienceIs a personal genome sequence worth $350,000?By Daniel MacArthur